Literature DB >> 8326460

Immunohistochemical distribution of heart-type fatty acid-binding protein immunoreactivity in normal human tissues and in acute myocardial infarct.

K Watanabe1, H Wakabayashi, J H Veerkamp, T Ono, T Suzuki.   

Abstract

The cellular distribution of heart-type fatty acid-binding protein (H-FABP) immunoreactivity was examined in normal human tissues using a polyclonal antibody against human H-FABP. Immunoreactivity was detected in cardiomyocytes of both ventricles and atria as well as in all striated muscles investigated. In addition, staining was frequently observed in parietal cells of the stomach, renal epithelial cells, acinar and ductal cells of the breast, ductal cells of the salivary gland, corpus luteum, and Leydig cells of the testis. Adipocytes and vascular endothelial cells were positive but other tissues and cells examined were negative. Old infarcts of the heart replaced by fibrous connective tissues were not labelled. Necrotic cardiomyocytes and morphologically normal cardiomyocytes in acute ischaemic lesions 1 h after onset showed reduced or no H-FABP immunoreactivity. Thus, decreased immunoreactivity for H-FABP may be a good histological marker of damaged cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326460     DOI: 10.1002/path.1711700110

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Distinct morphological and immunohistochemical features and different growth rates among four human neuroblastomas heterotransplanted into nude mice.

Authors:  Nobuo Hoshi; Jiro Hitomi; Takashi Kusakabe; Takeaki Fukuda; Masayuki Hirota; Toshimitsu Suzuki
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

Review 2.  Emerging Roles of Vascular Endothelium in Metabolic Homeostasis.

Authors:  Xinchun Pi; Liang Xie; Cam Patterson
Journal:  Circ Res       Date:  2018-08-03       Impact factor: 17.367

Review 3.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

Review 4.  Novel Risk Stratification Assays for Acute Coronary Syndrome.

Authors:  Haitham M Ahmed; Stanley L Hazen
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 5.  Possible involvement of fatty acid binding proteins in psychiatric disorders.

Authors:  Yui Yamamoto; Yuji Owada
Journal:  Anat Sci Int       Date:  2021-02-18       Impact factor: 1.741

Review 6.  Endothelial fatty acid transport: role of vascular endothelial growth factor B.

Authors:  Carolina Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Ulf Eriksson
Journal:  Physiology (Bethesda)       Date:  2013-03

7.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.

Authors:  Harun Elmasri; Cagatay Karaaslan; Yaroslav Teper; Elisa Ghelfi; Meiqian Weng; Tan A Ince; Harry Kozakewich; Joyce Bischoff; Sule Cataltepe
Journal:  FASEB J       Date:  2009-07-22       Impact factor: 5.191

8.  Alpha-fetoprotein-producing gastric carcinoma: biological properties of a cultured cell line.

Authors:  M Sekiguchi; Y Fujii; A Saito; T Suzuki; Y Shiroko; H Nakamura; K Hasumi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

9.  Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Authors:  Harsh Goel; Joshua Melot; Matthew D Krinock; Ashish Kumar; Sunil K Nadar; Gregory Y H Lip
Journal:  Ann Med       Date:  2020-08-04       Impact factor: 4.709

10.  FABP3 in the Anterior Cingulate Cortex Modulates the Methylation Status of the Glutamic Acid Decarboxylase67 Promoter Region.

Authors:  Yui Yamamoto; Hiroyuki Kida; Yoshiteru Kagawa; Yuki Yasumoto; Hirofumi Miyazaki; Ariful Islam; Masaki Ogata; Yuchio Yanagawa; Dai Mitsushima; Kohji Fukunaga; Yuji Owada
Journal:  J Neurosci       Date:  2018-10-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.